ARICI MARTINA

Frosio, A., Marchese, P., Bertoli, G., Molla, D., Arici, M., Bartolucci, C., et al. (2026). Hypokalemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation. EUROPACE, 28(2) [10.1093/europace/euaf160]. Dettaglio

Vinarsky, V., Pagliari, S., Aldabash, B., Martino, F., Mazzotti, C., Jirakova, K., et al. (2025). YAP1 reactivation in cardiomyocytes following ECM remodelling contributes to the development of contractile force and sarcomere maturation. CELL DEATH DISCOVERY, 11(1) [10.1038/s41420-025-02793-2]. Dettaglio

Arici, M., Hsu, S., Ferrandi, M., Barassi, P., Ronchi, C., Torre, E., et al. (2024). Selective SERCA2a activator as a candidate for chronic heart failure therapy. JOURNAL OF TRANSLATIONAL MEDICINE, 22(1) [10.1186/s12967-024-04874-9]. Dettaglio

Metallo, A., D'Angeli, V., Arici, M., Rocchetti, M. (2024). Intracellular Ca2+ dynamics modulation by istaroxime and its metabolite in pulmonary artery smooth muscle cells. VASCULAR PHARMACOLOGY, 155(June 2024), 20-20 [10.1016/j.vph.2024.107334]. Dettaglio

Arici, M., Hsu, S., Ferrandi, M., Barassi, P., Ronchi, C., Torre, E., et al. (2024). Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment. Intervento presentato a: XXIV Congress of the italian society of cardiovascular research, Imola, Italy [10.1016/j.vph.2024.107295]. Dettaglio